Answers are grounded in this paper and cite their sources.
UNLABELLED: This review describes the different gene therapy technologies applied to approach lysosomal storage disorders, monogenic conditions, with known genetic and biochemical defects, for many of which animal models are available. Both viral and nonviral procedures are described, underlying the specific needs that the treatment of genetic disorders requires. CONCLUSIONS: Lysosomal storage disorders represent a good model of study of gene therapeutic procedures that are, or could be, relevant to the treatment of several other mendelian diseases.
No takes yet. Share an insight, caveat, or question.
Tomanin et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: